Coverage
-
August 22, 2025
Several of Rite Aid's executives have escaped a securities fraud suit accusing them of making misleading statements about the pharmacy retailer's opioid-related liabilities, with a Pennsylvania federal court finding they sufficiently cautioned investors about the company's ongoing legal battles.
1 other articles on this case.
View all »